Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD

Eur Respir J. 2020 May 27;55(5):1902412. doi: 10.1183/13993003.02412-2019. Print 2020 May.

Authors

Samantha J Thulborn^{1

2}, Jennifer L Cane^{1

2}, Clare Connolly^{1

2}, Catherine Borg^{1

2}, Kelly L Moffitt³, David Ribeiro³, Charlene Robb³, Richard E K Russell¹, Mona Bafadhel¹

Affiliations

¹ Respiratory Medicine Unit, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.
² Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
³ ProAxsis Ltd, Belfast, UK.

PMID: 32060063
DOI: 10.1183/13993003.02412-2019

No abstract available

Publication types

Comparative Study
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Female
Humans
Immunoassay
Leukocyte Elastase / metabolism*
Male
Middle Aged
Neutrophils / metabolism
Pulmonary Disease, Chronic Obstructive / physiopathology*
Respiratory Function Tests
Sensitivity and Specificity
Sputum / metabolism

Substances

Leukocyte Elastase

Grants and funding